Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: From 2011 to 2013, the Global Fund (GF) supported needle and syringe programmes in Mexico to prevent transmission of HIV among people who inject drugs. It remains unclear how GF withdrawal affected the costs, quality and coverage of needle and syringe programme provision.

Design: Costing study and longitudinal cohort study.

Setting: Tijuana, Mexico.

Participants: Personnel from a local needle and syringe programme (n=6) and people who inject drugs (n=734) participating in a longitudinal study.

Primary Outcome Measures: Provision of needle and syringe programme services and cost (per contact and per syringe distributed, in 2017 $USD) during GF support (2012) and after withdrawal (2015/16). An additional outcome included needle and syringe programme utilisation from a concurrent cohort of people who inject drugs during and after GF withdrawal.

Results: During the GF period, the needle and syringe programme distributed 55 920 syringes to 932 contacts (60 syringes/contact) across 14 geographical locations. After GF withdrew, the needle and syringe programme distributed 10 700 syringes to 2140 contacts (five syringes/contact) across three geographical locations. During the GF period, the cost per harm reduction contact was approximately 10-fold higher compared with after GF ($44.72 vs $3.81); however, the cost per syringe distributed was nearly equal ($0.75 vs $0.76) due to differences in syringes per contact and reductions in ancillary kit components. The mean log odds of accessing a needle and syringe programme in the post-GF period was significantly lower than during the GF period (p=0.02).

Conclusions: Withdrawal of GF support for needle and syringe programme provision in Mexico was associated with a substantial drop in provision of sterile syringes, geographical coverage and recent clean syringe utilisation among people who inject drugs. Better planning is required to ensure harm reduction programme sustainability is at scale after donor withdrawal.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352756PMC
http://dx.doi.org/10.1136/bmjopen-2018-026298DOI Listing

Publication Analysis

Top Keywords

needle syringe
40
syringe programme
32
people inject
20
inject drugs
20
syringe
13
needle
10
programme
9
global fund
8
syringe distributed
8
programme distributed
8

Similar Publications

Two patients (a 7-year-old female and a 61-year-old male) had poor intraocular pressure control after XEN gel stent implantation. During the process of filtering bleb repair, the XEN gel implant retreated into the anterior chamber, and the limbal and corneal incisions were made. After the implant in the anterior chamber was taken out, it was implanted into the anterior chamber again from the original scleral tunnel for the female patient, while it was re-punctured into the anterior chamber with a 1-ml syringe needle at another site for the male patient.

View Article and Find Full Text PDF

Objective To evaluate the effectiveness of ultrasound-guided marker placement in the precise localization of breast lesions, facilitate accurate surgical resection, and monitor tumor response during and after neoadjuvant chemotherapy. Materials and methods From January 2022 to December 2022, 70 female patients with breast carcinoma underwent a trial of metallic marker insertion into the tumor. The markers were made by cutting 5CC disposable syringe needles having a total length of 5 mm.

View Article and Find Full Text PDF

Background: One of the most important occupational injuries experienced by nurses is needle sticks. The causes and factors of needle sticks are not fully known. This study was conducted with the aim of investigating the relationship between sensation-seeking, aggressiveness, and self-confidence with needle stick and Sharp injuries among nurses in a children's and women's hospital.

View Article and Find Full Text PDF

Background: HIV and Hepatitis C (HCV) are blood borne infections (BBIs) that remain a significant cause of global morbidity and mortality among people who inject drugs (PWID). UNAIDS and WHO have set goals for the elimination of viral hepatitis and HIV as major public health threats by 2030. To achieve these targets, innovative strategies are required among marginalized populations such as PWID, especially in resource-limited countries where coverage of harm reduction services is often limited.

View Article and Find Full Text PDF

A central challenge in the opioid crisis in the US has been the underuse of lifesaving treatment and harm reduction programs. Conventional explanations focus on limited access to care when services are not convenient, affordable, or timely. However, these factors exist downstream from other fundamental causes of low utilization.

View Article and Find Full Text PDF